Ask the experts: should we screen for Alzheimer’s disease? (Part 3: Current diagnostics & future biomarkers)

This week’s ‘Ask the experts’ column with Maria Carrillo (Alzheimer’s Association), Linda Nazarko (London North West Healthcare NHS Trust, UK), Gabriel Vargas (Amgen, CA, USA) & Henrik Zetterberg (University of Gothenburg, Sweden) focuses on the often controversial topic of screening for Alzheimer’s disease. Over the past 2 days we have introduced the topic and drilled down into the pros and cons of screening. In this final installment we will discuss the current opporutnities for Alzheimer's diagnosis and future hopes for efficacious biomarkers. You can find out more about the panelists at the bottom of this post. What are the standard...